Safety and effects of DMT in healthy adults and those with depression
Part of Mental health clinical trials.
This trial studies the safety and effects of DMT, a psychedelic compound, in healthy volunteers and people with major depressive disorder (MDD) who haven't responded well to antidepressants. It aims to see how DMT affects the brain and mood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 65 years old
- Your body mass index is between 18 and 35
- You are not currently pregnant, breastfeeding, or planning to become pregnant
- You agree not to take any new medications, street drugs, or alcohol during the study
- If you have depression, your mental health clinician supports your participation
- You do not have a history of hallucinogen use disorder or serious heart problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether psilocybin can help people with major depression who are currently having a depressive episode. It aims to understand how the treatment works and if it is safe and effective.
This study tests an investigational medication (CYB003) for people with major depression whose current antidepressant isn't working well enough. It looks at whether this treatment can help improve depression symptoms.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This trial tests whether a single dose of psilocybin can help people with treatment-resistant depression by changing how they focus on themselves. It aims to understand how psilocybin affects brain activity and self-related thinking.
This trial tests if inhaling DMT can help treat moderate to severe major depression. You may qualify if your depression has lasted at least two weeks and you have not changed medications recently.
This study tests whether a combination of DMT (a psychedelic) and propofol (a sedative) can help treat depression. You will receive both medicines in a hospital setting, and the team will monitor your response.
Hear when a new Major Depression Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.